MedTrace Logo

Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

NCT02561845 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-05-11

No results posted yet for this study

Summary

Most PCI patients are at very high cardiovascular (CV) risk, and as such here is an increased need for intensive lipid management in Percutaneous Coronary Intervention (PCI) patients and the population is well suited to demonstrating rosuvastatin's low density lipoprotein-cholesterol (LDL-C) lowering efficacy.Most PCI patients are at very high CV risk, and as such here is an increased need for intensive lipid management in PCI patients and the population is well suited to demonstrating rosuvastatin's LDL-C lowering efficacy.The purpose of this study is to observe the effectiveness of statins on lipid level reduction (LDL-C, high density lipoprotein-cholesterol (HDL-C), Triglyceride (TG), and non-HDL-C) and lipid goal attainment according to recent guidelines.

Conditions

  • PCI Patients

Interventions

DRUG

rosuvastatin

5mg, 10mg, 20mg

Sponsors & Collaborators

Principal Investigators

  • Yundai Chen, MD,PhD · Chinese PLA General Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02561845 on ClinicalTrials.gov